An 18-year-old male patient was transferred to our hospital for evaluation of recent-onset generalized weakness, difficulty walking, and a 3-week history of progressive numbness in his fingertips and distal extremities. The patient's mother reported that she had experienced 4 similar episodes of lower-body weakness at the age of 16 years that had self-resolved. In addition, the patient's brother was hospitalized for a similar episode of lower-body weakness that had also selfresolved.
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The patient's neurologic exam was notable for difficulty walking, with an unsteady, wide-based gait. He could not walk on toes or heels without assistance; otherwise he had full strength on manual muscle testing. Sensory exam revealed decreased appreciation of sensation to touch, temperature, vibration and proprioception (position sense) from feet proximally to knees and fingertips to palms.
Laboratory findings were as follows: plasma methylmalonic acid (MMA) 5 was highly increased: 17.4 µmol/L (reference interval: 0-0.29 µmol/L); total homocysteine was highly increased: 125 µmol/L (reference interval: <12.5 µmol/L); vitamin B12 was low: 188 pg/mL (200-1100 pg/mL); and liver enzymes were slightly increased: alanine transaminase (ALT): 54 U/L (reference interval: 3-35 U/L); aspartate transaminase (AST): 48 U/L (reference interval: 15-46 U/L). All other blood test results were within reference intervals except for a slightly increased red cell distribution width (RDW)-CV, 18.0% (reference interval: 11.5%-14.5%) and very slightly decreased hematocrit (HCT), 38.4% (reference interval: 39%-53%). There was no laboratory evidence of megaloblastic anemia.
The patient was treated with 1 intramuscular injection of cyanocobalamin and referred to an adolescent clinic for psychosocial evaluation, but he then left the hospital against medical advice before further treatment.
Eight months later, he presented with similar findings with loss of lower-extremity proprioception and vibratory sense, spastic diplegia with foot drop, and widebased ataxic gait. He was admitted to the hospital again due to worsening gait progressing to a nonambulatory status. His laboratory
